Response to letter regarding article, "Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis"

Affiliations

¹ Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Center, Montreal, QC, Canada.
² Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, California, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada, University Health Network, Toronto, ON, Canada.
³ Division of Cardiology, McGill University Health Center, Montreal, QC, Canada.
⁴ Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University, Montreal, QC, Canada.
⁵ Division of Cardiology, University of British Columbia, Vancouver, BC, Canada.
⁶ Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada, Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
⁷ Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.

Comment

Mitesh Shah et al. Circulation. 2014.

. 2014 Dec 23;130(25):e428-9.

doi: 10.1161/CIRCULATIONAHA.114.012785.

¹ Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Center, Montreal, QC, Canada.
² Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, California, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada, University Health Network, Toronto, ON, Canada.
³ Division of Cardiology, McGill University Health Center, Montreal, QC, Canada.
⁴ Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University, Montreal, QC, Canada.
⁵ Division of Cardiology, University of British Columbia, Vancouver, BC, Canada.
⁶ Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada, Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
⁷ Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.

No abstract available

Comment on

Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.
Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Guo H, Pilote L. Shah M, et al. Circulation. 2014 Mar 18;129(11):1196-203. doi: 10.1161/CIRCULATIONAHA.113.004777. Epub 2014 Jan 22. Circulation. 2014. PMID: 24452752
Letter by Qureshi et al regarding article, "Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis".
Qureshi W, Alirhayim Z, Khalid F. Qureshi W, et al. Circulation. 2014 Dec 23;130(25):e427. doi: 10.1161/CIRCULATIONAHA.114.010090. Circulation. 2014. PMID: 25539526 No abstract available.